Comparative safety of bone remodeling agents with a focus on osteoporosis therapies

被引:12
|
作者
Kleerekoper, M
Schein, JR
机构
[1] Wayne State Univ, Sch Med, Dept Internal Med, Div Endocrinol, Detroit, MI 48201 USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2001年 / 41卷 / 03期
关键词
D O I
10.1177/00912700122010050
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article reviews the different treatments currently available for osteoporosis and examines the benefits and adverse events that are associated with each. While emphasizing safety considerations, this review summarizes the following treatments for osteoporosis: calcium supplements, fluoride, hormone replacement therapy, raloxifene, bisphosphonates, salmon calcitonin, and calcitriol. Before prescribing any of these agents, the clinician should review the risk/benefit profile of each drug in the context of the individual patient's history, concomitant diseases, concurrent medications, and general physical condition. Journal of Clinical Pharmacology, 2001;41:239-250 (C) 2001 the American College of Clinical Pharmacalogy.
引用
收藏
页码:239 / 250
页数:12
相关论文
共 50 条
  • [21] Bone targeted therapies: new agents
    Barth, Claire
    Massard, Christophe
    Vignot, Stephane
    BULLETIN DU CANCER, 2013, 100 (11) : 1215 - 1221
  • [22] Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis
    Ghayor, Chafik
    Weber, Franz E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09)
  • [23] REMODELING OF BONE AROUND HYDROXYAPATITE AND TITANIUM IN EXPERIMENTAL OSTEOPOROSIS
    HAYASHI, K
    UENOYAMA, K
    MASHIMA, T
    SUGIOKA, Y
    BIOMATERIALS, 1994, 15 (01) : 11 - 16
  • [24] BONE REMODELING IN TYPE-I OSTEOPOROSIS - REPLY
    ERIKSEN, EF
    HODGSON, SF
    EASTELL, R
    CEDEL, SL
    OFALLON, WM
    RIGGS, BL
    JOURNAL OF BONE AND MINERAL RESEARCH, 1991, 6 (01) : 96 - 97
  • [25] The roles of exercise in bone remodeling and in prevention and treatment of osteoporosis
    Yuan, Yu
    Chen, Xi
    Zhang, Lingli
    Wu, Juanni
    Guo, Jianming
    Zou, Dongchen
    Chen, Binglin
    Sun, Zhongguang
    Shen, Chao
    Zou, Jun
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2016, 122 (02): : 122 - 130
  • [26] Galectin-8 as a regulator of bone remodeling and osteoporosis
    Vinik, Yaron
    Shatz-Azoulay, Hadas
    Zick, Yehiel
    GLYCOBIOLOGY, 2016, 26 (12) : 1428 - 1429
  • [27] CLINICAL USE OF BIOCHEMICAL MARKERS OF BONE REMODELING IN OSTEOPOROSIS
    DELMAS, PD
    BONE, 1992, 13 : S17 - S21
  • [28] Biochemical Markers of Bone Remodeling in Osteoporosis Current Concepts
    Indumati, V
    Patil, V. S.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2010, 4 (01) : 2089 - 2097
  • [29] BONE REMODELING IN OSTEOPOROSIS ASSOCIATED WITH RHEUMATOID-ARTHRITIS
    KROGER, H
    ARNALA, I
    ALHAVA, EM
    CALCIFIED TISSUE INTERNATIONAL, 1991, 49 : S90 - S90
  • [30] Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies
    I. Byrjalsen
    D. J. Leeming
    P. Qvist
    C. Christiansen
    M. A. Karsdal
    Osteoporosis International, 2008, 19 : 339 - 348